Role of argatroban infusion in controlling clot formation in post-cardiac surgical extracorporeal membrane oxygenation in pediatrics: A case series of three patients

Anticoagulation in pediatric patients on extracorporeal membrane oxygenation (ECMO) presents significant challenges. Direct thrombin inhibitors (DTIs), such as argatroban, are increasingly considered when heparin is ineffective or contraindicated. However, guidelines regarding optimal dosing and monitoring remain established. This case series examines three pediatric patients who received argatroban infusion following cardiac surgery. We focus on titration challenges, complications, and outcomes. Patient 1, a 3-month-old girl, required a gradual increase in argatroban to 0.7 mcg/kg/min over 8 days. Patient 2, a 3-year-old boy, transitioned to argatroban due to suspected heparin-induced thrombocytopenia (HIT) and required doses up to 1.43 mcg/kg/min. Patient 3, a 23-month-old boy, reached 2.13 mcg/kg/min over 39 days. While patients were successfully decannulated, complications included arterial thrombosis, circuit thrombosis, and mild intracranial hemorrhage. In our series, effective argatroban doses ranged widely (0.18 to 2.13 mcg/kg/min), highlighting the need for individualized dosing, while optimal monitoring strategies remain to be established; lower doses are recommended for patients with hepatic impairment.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Anticoagulation in pediatric patients on extracorporeal membrane oxygenation (ECMO) presents significant challenges.

Leech-derived molecules this paper discusses, each with a full profile in the ASH compound registry:

Узнайте, как это исследование связано с клинической практикой

More peer-reviewed studies in Клинические исследования.

• Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
• Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
• Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
• Investigation of the therapeutic effects of medicinal leech treatment on lower extremity ischemia-reperfusion injury — Ünal K et al. (2026)
• Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
• HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
• Hirudotherapy Efficacy and Complications in the Management of Microsurgical Breast Reconstruction: A Systematic Review — Foppiani J et al. (2024)
• Hirudotherapy in Wound Healing — Nair H et al. (2022)

Browse all ASH-analysed research →